Turillazzi E, Greco P, Neri M, Pomara C, Riezzo I, Fineschi V
Department of Forensic Pathology, University of Foggia, Ospedale Colonnello D'Avanzo, Via degli Aviatori 1, 71100 Foggia, Italy.
Forensic Sci Int. 2008 Jul 18;179(1):e5-8. doi: 10.1016/j.forsciint.2008.03.021. Epub 2008 May 12.
The true incidence of anaphylactic latex reactions and their associated morbidity and mortality remain poorly defined. It is noteworthy that a number of groups of individuals are at risk for anaphylactic reactions to latex during surgical and medical procedures; one of these groups is represented by the obstetric and gynaecologic population. A case of unrecognized first anaphylactic reaction to latex in a pregnant woman patient who underwent a caesarean section is presented. The diagnosis of latex allergy was missed and the following day the woman underwent a surgical re-exploration complicated by fatal cardiovascular arrest. At post-mortem examination, pulmonary mast cells in the bronchial walls and capillary septa were identified and a great number of degranulating mast cells with tryptase-positive material outside the cells was documented. A post-mortem latex-specific IgE test showed a high titre (14.00 U/I). Latex-induced fatal anaphylactic shock was recorded as the cause of death. This case highlights some of the practical difficulties in the initial diagnosis and subsequent investigation of fatal anaphylactic reaction during anaesthesia. Anaphylaxis is often misdiagnosed because many other pathologic conditions may present identical clinical manifestations, so anaphylactic shock must be differentiated from other causes of circulatory collapse. Although latex allergy usually has a delayed onset after the start of the surgery and most often a slow onset too, it should be always suspected if circulatory collapse and respiratory failure occur during surgery, even if the patient does not belong to a risk group; in the presence of identified risk factors for latex allergy a well-founded suspicion must be stronger, leading to an immediate discontinuation of the potential trigger.
乳胶过敏反应的真实发病率及其相关的发病率和死亡率仍未明确界定。值得注意的是,在外科手术和医疗程序中,有几类人群有发生乳胶过敏反应的风险;产科和妇科人群就是其中之一。本文介绍了一例在剖宫产手术中未被识别出首次发生乳胶过敏反应的孕妇病例。乳胶过敏的诊断被漏诊,第二天该名妇女接受了再次手术探查,结果并发致命的心脏骤停。尸检时,在支气管壁和毛细血管间隔中发现了肺肥大细胞,并记录到大量细胞外有类胰蛋白酶阳性物质的脱颗粒肥大细胞。尸检乳胶特异性IgE检测显示高滴度(14.00 U/I)。记录乳胶诱导的致命过敏反应为死亡原因。该病例凸显了麻醉期间致命过敏反应的初步诊断及后续调查中的一些实际困难。过敏反应常被误诊,因为许多其他病理状况可能呈现相同的临床表现,所以必须将过敏性休克与循环衰竭其他原因区分开来。虽然乳胶过敏通常在手术开始后有延迟发作,而且大多发作也较缓慢,但如果手术期间发生循环衰竭和呼吸衰竭,即使患者不属于风险人群,也应始终怀疑乳胶过敏;如果存在已确定的乳胶过敏风险因素,有充分依据的怀疑必须更强,要立即停止使用可能的触发物。